Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital, discusses the cost-effectiveness of varying weight loss interventions. The ...

A new study published in the Journal of Telemedicine and Telecare shows a telehealth program involving video coaching and self-monitoring with mHealth devices could be an effective way for helping ...

Health care leaders and professionals constantly seek ways to improve their clients’ lifestyles. In recent times, nutritional programs have emerged as a tool that provides a balanced diet to drive ...

Can the new GLP-1s help prevent cancer before it starts by tackling obesity and all the dysfunctional metabolic pathways that ...

Healthy weight loss is all about finding the right balance between exercise and eating healthy, and a weight loss program can help you do that as you work to reach your health goals. However, it can ...

Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...